valproic acid and clozapine

valproic acid has been researched along with clozapine in 119 studies

Research

Studies (119)

Timeframe	Studies, this research(%)	All Research%
pre-1990	2 (1.68)	18.7374
1990's	16 (13.45)	18.2507
2000's	42 (35.29)	29.6817
2010's	46 (38.66)	24.3611
2020's	13 (10.92)	2.80

Authors

Authors	Studies
Andrews, PR; Craik, DJ; Martin, JL	1
Strassburg, CP; Tukey, RH	1
Topliss, JG; Yoshida, F	1
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL	1
Andricopulo, AD; Moda, TL; Montanari, CA	1
Lombardo, F; Obach, RS; Waters, NJ	1
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM	1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV	1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A	1
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM	1
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV	1
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ	1
Glen, RC; Lowe, R; Mitchell, JB	1
Ekins, S; Williams, AJ; Xu, JJ	1
Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC	1
Honda, K; Izumi, T; Miyaji, Y; Nakayama, S; Okazaki, O; Okudaira, N; Shiosakai, K; Sugiyama, D; Suzuki, W; Takakusa, H; Watanabe, A	1
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V	1
Barber, J; Dawson, S; Kenna, JG; Paul, N; Stahl, S	1
Atzpodien, EA; Csato, M; Doessegger, L; Fischer, H; Lenz, B; Schmitt, G; Singer, T	1
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY	1
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Jones, LH; Nadanaciva, S; Rana, P; Will, Y	1
Filipek, B; Gunia-Krzyżak, A; Marona, H; Nitek, W; Pańczyk, K; Pękala, E; Rapacz, A; Słoczyńska, K; Waszkielewicz, AM; Żelaszczyk, D; Żesławska, E	1
Fünfgeld, EW; Henkel, H; Kausen, J; Klenke, D; Zimmermann, P	1
Longo, LP; Salzman, C	1
Costello, LE; Suppes, T	1
Finley, P; Warner, D	1
Calabrese, JR; Woyshville, MJ	1
Castillo, J; Centorrino, F; Kando, JC; Tohen, M	1
Meltzer, HY; Ranjan, R	1
Baldessarini, RJ; Centorrino, F; Cohen, BM; Flood, JG; Huston-Lyons, D; Volpicelli, SA	1
Baldessarini, RJ; Centorrino, F; Flood, JG; Frankenburg, FR; Kando, J; Puopolo, PR; Volpicelli, SA	1
Grimmell, K; Mazure, CM; Sernyak, M; Vojvoda, D	1
Rush, AJ; Suppes, T	1
Keck, PE; McElroy, SL; Strakowski, SM	1
Freeman, MP; Stoll, AL	1
Avenoso, A; Facciolà, G; Madia, AG; Perucca, E; Scordo, MG; Spina, E; Ventimiglia, A	1
Deckert, J; Retz, W; Supprian, T	1
Giannella, R; Lanzio, M; Maule, S; Villari, V	1
Cagliero, E; Goff, DC; Gray, C; Hayden, DL; Henderson, DC; Nasrallah, RA; Schoenfeld, DA	1
Ames, D; Bisheff, S; Mendoza, A; Pierre, JM; Sun, A; Wirshing, WC	1
Calabrese, JR; Gajwani, P	1
Ghaemi, SN; Guille, C; Sachs, GS	1
Miller, PR	1
Beraus, W; Conca, A; König, P; Waschgler, R	1
Nemeroff, CB	1
Ghaemi, SN	1
Keunen, RW; Nicolai, J; Smith, SJ	1
Adesanya, A; Pantelis, C	1
Hirschmann, S; Kurs, R; Madeb, R; Modai, I; Turkie, A	1
Freeman, MP; Gelenberg, AJ; Gnanadesikan, M	1
Agam, G; Belmaker, RH; Kozlovsky, N; Nadri, C	1
Fleischhacker, WW; Hofer, A; Hummer, M	1
Grady, MM; Stahl, SM	1
Botts, S; Coffey, G; de Leon, J	1
Bryois, Ch; Sahli, Ch	1
Brar, JS; Chengappa, KN; Imbarlina, MJ; Johnston, PR; Marwah, S; Parepally, H; Sarkar, S	1
Foster, R; Olajide, D	1
Begum, M	1
Chan, YC; Hankins, MB; Miller, KM; Shaheen, N; Votolato, NA	1
Danielyan, A; Kowatch, RA	1
Chan, KT; Choi, WK; Hon-Kee Cheung, H; Lai, J; Leung, SP; Mak, T; Ng, RM; Wai-Kiu Tsang, A; Wong, JO	1
Conley, RR; Feldman, S; Kelly, DL; McMahon, RP; Richardson, CM; Yu, Y	1
Corona-Vazquez, T; Lopez-Meza, E; Ramirez-Bermudez, J; Ruano-Calderon, LA	1
Bhatti, MA; Reeve, E; Zander, J	1
Bajbouj, M; Danker-Hopfe, H; Gallinat, J; Hellen, F; Lang, UE; Lisanby, SH; Neu, P; Vesper, J	1
Duggal, HS	1
Dressing, H; Englisch, S; Knopf, U; Kuwilsky, A; Zink, M	1
Durand, M; Forget, K; Grignon, S; Huppert, T	1
Costa, E; Dong, E; Grayson, DR; Guidotti, A; Nelson, M	1
Caetano, D	1
Chan, WF; Chung, KF; Lai-wah Dunn, E; Pui-yin Chung, J; Shiu-yin Chong, C; Wai-nang Tang, O	1
Hauser, D; Ladds, B; Mejia, C; Thomas, P	1
Alvarez-Dobaño, JM; Arrojo-Romero, M; Carballal-Calvo, F; Codesido-Barcala, R; de Leon, J; Fernández-Pérez, R; Suárez-Antelo, J	1
Grosić, V; Mihanović, M; Presecki, P; Silić, A	1
Di Cosimo, D; Girardi, N; Kotzalidis, GD; Lazanio, S; Manfredi, G; Savoja, V; Talamo, A; Tatarelli, R; Vento, A	1
Huff, W; Klosterkötter, J; Kuhn, J; Schilbach, L; Timmermann, L; Weiss, PH	1
Rushlow, WJ; Sutton, LP	1
Bowen, DJ; Braude, S; Lucas, NL	1
Aydinoglu, U; Canan, F; Sinani, G	1
Fitzgerald, PB; McNeil, JJ; Ronaldson, KJ; Taylor, AJ; Topliss, DJ; Wolfe, R	1
Jacob, KS; Jacob, M; Kuruvilla, A; Poonkuzhali, B; Rajkumar, AP	1
Akbarian, S; Halene, T; Hasan, A; Mitchell, A; Schneider, A	1
Chen, CC; Chen, WJ; Kuo, CJ; Liao, YT; Liu, HC; Yang, SY	1
Cooley, AT; de Leon, J; Riesselman, A; Strobl, B	1
Allen, MB; Baker, JC; Nuernberger, JE; Vargo, KK	1
Ene-Stroescu, V; Nguyen, T; Waiblinger, BE	1
Cadilhe, DV; Cardoso, SC; Paulsen, Bda S; Rehen, SK; Stelling, MP	1
Ansermot, N; Crettol, S; de Leon, J; Diaz, FJ; Eap, CB; Spina, E	1
Campanella, D; De Berardis, D; Fornaro, M; Giannantonio, MD; Iasevoli, F; Martinotti, G; Napoletano, C; Olivieri, L; Rapini, G; Serroni, N; Valchera, A	1
Joyce, DW; Mateos Fernandez, MJ; Sarkar, SN; Shergill, SS; Tracy, DK	1
Gaughran, F; Gee, S; MacCabe, JH; Meyer, N; Mijovic, A; Shergill, S; Taylor, D; Whiskey, E	1
Aebischer, B; Akboga, MK; Akdamar, G; Alcalay, RN; Álvarez-Pérez, S; Aydogdu, S; Balci, KG; Barcaro, G; Bišová, K; Blanco, JL; Brewer, SH; Caruthers, SD; Ceylan, O; Chadwick, JA; Chang, DD; Che, JM; Chen, QQ; Chen, W; Chen, Z; Chung, M; Chung, W; Colecraft, HM; Coteli, E; Dogan, H; Dong, S; Elsig, S; Fahn, S; Fang, XJ; Feng, MG; Fenlon, EE; Floyd, KT; Fokdal, L; Ford, B; Fortunelli, A; Freudenberg, R; Gan-Or, Z; García, ME; Gillham, C; Giovannelli, D; Goertz, RS; Gulati, V; Haie-Meder, C; Hao, YY; Hatano, K; Hines, KJ; Hines, SM; Hirakawa, H; Hoskin, P; Hu, JH; Huang, P; Huang, Y; Hubicka, U; Inoue, Y; Ishii, N; Janssen, PM; Jin, Z; Johnson, A; Jürgenliemk-Schultz, I; Kaineder, K; Kamei, K; Kang, U; Karatas, F; Kash, TL; Katayama, Y; Keupp, J; Kirisits, C; Kisacik, H; Kodama, K; Kotzerke, J; Kryczyk, A; Kuhness, D; Kuo, S; Lanza, GM; Le Bris, N; Levin, DE; Levy, OA; Li, B; Li, H; Li, X; Liang, GD; Liang, Y; Liao, RQ; Lin, JT; Lindegaard, JC; Liong, C; Liu, B; Liu, C; Liu, GH; Liu, L; Liu, Q; Liu, X; Lowe, J; Lowery-Gionta, EG; Ma, YH; Maden, O; Mankad, V; Marder, KS; Marshall, SA; Martínez-Nevado, E; Maucksch, U; Mazeron, R; Mazzone, CM; Mazzoni, P; Mezricky, D; Mizokami, Y; Naumann, A; Navarro, M; Netzer, FP; Neurath, MF; Nie, Q; Oliva, P; Ozeke, O; Peláez, T; Pfeifer, L; Pleil, KE; Pomp, S; Pötter, R; Puckerin, AA; Rafael-Fortney, JA; Raman, SV; Rastogi, N; Řezanka, M; Řezanka, T; Rinker, JA; Rouleau, GA; Runge, R; Sahin, MD; Sakai, A; Schmieder, AH; Schmitz, AJ; Schultz, EJ; Šegedin, B; Sementa, L; Shen, Y; Shiotsuki, I; Shirahama, M; Staley, J; Starovoytov, V; Sterrer, M; Strobel, D; Sturdza, A; Subramanyam, P; Surnev, S; Swager, SA; Taeymans, J; Tan, H; Tan, LT; Tanderup, K; Temizhan, A; Terao, T; Thiele, TE; Tran, T; Tucker, MJ; Vetriani, C; Vítová, M; Wang, JP; Wang, L; Wang, M; Wang, X; Waters, CH; Weng, SX; Wickline, SA; Wildner, D; Wodarcyk, AJ; Wolf, P; Wu, L; Wu, YL; Wunderlich, G; Xiong, L; Xu, P; Yang, GS; Yang, XN; Yang, Y; Yayla, C; Ying, SH; Zachleder, V; Zhang, XG; Zhang, XK; Zhang, Y; Zheng, JY; Zhong, WZ; Zhu, J; Zhu, YJ; Żmudzki, P	1
de Leon, J; Lana, F; Martí-Bonany, J	1
Kanofsky, JD; Woesner, ME	1
Ajnakina, O; Flanagan, RJ; Gaughran, F; Krivoy, A; Lally, J; MacCabe, JH; Malik, S; Pritchard, M; Shetty, H	1
Akhavanrezayat, A; Amlashi, SV; Behdani, F; Ferns, GA; Ghayour-Mobarhan, M; Hebrani, P; Roudbaraki, SN; Saberi-Karimian, M; Tayefi, M	1
Baroni, S; Betti, L; Ciapparelli, A; DellʼOsso, L; Giannaccini, G; Lucacchini, A; Marazziti, D; Massimetti, E; Mucci, F; Palego, L	1
Deckert, J; Fischer, M; Hefner, G; Hohner, M; Hommers, L; Pfuhlmann, B; Scharl, M; Unterecker, S	1
Chen, RYY; Reznik, R; Stanford, P	1
Chung, IW; Jeong, SH; Jeong, SW; Jung, HY; Kim, HS; Kim, KK; Kim, SH; Kim, YS; Youn, T	1
Benyamina, A; Martelli, C; Petillion, A; Roméo, B	1
Andreassen, OA; Haslemo, T; Kyllesø, L; Molden, E; Smith, RL	1
Ağaoğlu, E; Ak, S; Anıl Yağcıoğlu, AE; Ertuğrul, A; Karahan, S; Karakaşlı, AA; Yazıcı, MK	1
de Leon, J	1
Jahołkowski, P; Kowalski, M; Niewiadomska, J; Świtaj, P; Wciórka, J	1
Fukuyama, K; Murata, M; Okada, M; Okubo, R; Shiroyama, T	1
Chen, HZ; Chen, YQ; Deng, SH; Fang, ZY; Hu, JQ; Li, L; Lu, HY; Shang, DW; Wang, ZZ; Wen, YG; Xie, HS; Zhang, M; Zhu, XQ	1
Ateb, S; Baha, D; Ben Rejeb, H; Benadhira, R; Bouaziz, N; Chammas, F; Fourati, T; Januel, D; Kalalou, K; Rosetti, R; Saba, G	1
Andrade, G; Câmara-Pestana, L; Simões do Couto, F	1
Adebayo, RA; Anıl Yağcıoğlu, AE; Arrojo-Romero, M; Ayub, M; Baptista, T; Bebawi, E; Bhattacharya, R; Bilbily, J; Bonelli, RM; Bousman, CA; Buckley, PF; Celofiga, A; Chan, SKW; Chopra, N; Citrome, L; Cohen, D; Correll, CU; Cotes, RO; Crespo-Facorro, B; Cubała, WJ; De Berardis, D; De Las Cuevas, C; de Leon, J; Decloedt, E; Eap, CB; Elkis, H; Ertuğrul, A; Every-Palmer, S; Farooq, S; Fernandez-Egea, E; Fountoulakis, KN; Freudenreich, O; González-Esquivel, DF; Grover, S; Gründer, G; Hiemke, C; Iglesias-Alonso, A; Iglesias-Garcia, C; Ignjatovic Ristic, D; Jung-Cook, H; Kaithi, AR; Kane, JM; Kelly, DL; Kim, SH; Kim, YS; Kirilochev, OO; Kopeček, M; Lana, F; Lane, HY; Lazary, J; Leung, JG; Lin, SK; LLerena, A; López-Jaramillo, C; Marder, SR; Masmoudi, R; McCollum, B; McGrane, I; Mohd Saffian, S; Molden, E; Motuca, M; Müller, DJ; Ng, CH; Nielsen, J; Olmos, I; Ortiz, BB; Otsuka, Y; Ouanes, S; Pacheco Palha, AJ; Pedro, MR; Procyshyn, RM; Quiles, C; Rădulescu, FŞ; Rajkumar, AP; Ricciardi, C; Rohde, C; Ruan, CJ; Sagud, M; Sanz, EJ; Schoretsanitis, G; Schulte, PFJ; Seifritz, E; Seppälä, N; Shelton, C; Silva, A; Siskind, D; Smith, RL; Solismaa, A; Soloviev, A; Spina, E; Švancer, P; Takeuchi, H; Tang, YL; Temmingh, H; Torres, R; Tsukahara, M; Verdoux, H; Villagrán-Moreno, JM; Wang, CY; Wang, G; Weizman, A; Wilkowska, A; Yecora, A; Zolezzi, M	1
Eriksson, L; Malacova, E; McMahon, K; Moudgil, V; Ramineni, V; Scott, J; Siskind, D; Vickers, M	1
Coleman, JK; Cotes, RO; De Leon, J; Goldsmith, DR; Koenig, M; McCollum, B; Shelton, C; Spivey, JK	1
Cirujeda, C; Concha, J; García, CB; Padilla, PP; Ribate, MP; Sangüesa, E	1
Anver, PC; Moideen, S; Uvais, NA	1
Chou, PH; Lin, CH; Wang, XY; Yang, CC	1
Kishi, Y; Kodama, M; Nakajima, S; So, R; Takeda, T; Takeuchi, H; Tsukahara, M; Yada, Y; Yamada, N; Yamashita, R; Yoshimura, Y	1
Jovanović, M; Lukić, V; Miljković, B; Milovanović, S; Panić, B; Vučićević, K	1

Reviews

15 review(s) available for valproic acid and clozapine

Article	Year
Human UDP-glucuronosyltransferases: metabolism, expression, and disease. Annual review of pharmacology and toxicology, 2000, Volume: 40 Topics: Autoimmunity; Chromosome Mapping; Glucuronides; Glucuronosyltransferase; Humans; Hyperbilirubinemia; Neoplasms; Steroids; Terminology as Topic	2000
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016
A medication algorithm for treatment of bipolar rapid cycling? The Journal of clinical psychiatry, 1995, Volume: 56 Suppl 3 Topics: Algorithms; Bipolar Disorder; Carbamazepine; Clozapine; Controlled Clinical Trials as Topic; Drug Administration Schedule; Drug Therapy, Combination; Electroconvulsive Therapy; Humans; Lithium; Treatment Outcome; Valproic Acid	1995
New developments in the pharmacologic treatment of schizoaffective disorder. The Journal of clinical psychiatry, 1996, Volume: 57 Suppl 9 Topics: Antidepressive Agents; Antipsychotic Agents; Carbamazepine; Clinical Trials as Topic; Clozapine; Drug Therapy, Combination; Humans; Psychotic Disorders; Receptors, Serotonin; Risperidone; Serotonin Antagonists; Treatment Outcome; Valproic Acid	1996
Mood stabilizer combinations: a review of safety and efficacy. The American journal of psychiatry, 1998, Volume: 155, Issue:1 Topics: Acetates; Amines; Anticonvulsants; Antipsychotic Agents; Bipolar Disorder; Calcium Channel Blockers; Clinical Trials as Topic; Clozapine; Cyclohexanecarboxylic Acids; Drug Therapy, Combination; Gabapentin; gamma-Aminobutyric Acid; Humans; Lithium; Risperidone; Valproic Acid	1998
An ever-increasing pharmacopoeia for the management of patients with bipolar disorder. The Journal of clinical psychiatry, 2000, Volume: 61 Supp 13 Topics: Acetates; Amines; Anticonvulsants; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Carbamazepine; Clozapine; Cyclohexanecarboxylic Acids; Drug Therapy, Combination; Electroconvulsive Therapy; Electromagnetic Phenomena; Fructose; Gabapentin; gamma-Aminobutyric Acid; Humans; Lamotrigine; Lithium; Olanzapine; Pirenzepine; Risperidone; Topiramate; Treatment Outcome; Triazines; Valproic Acid	2000
New treatments for bipolar disorder: the role of atypical neuroleptic agents. The Journal of clinical psychiatry, 2000, Volume: 61 Suppl 14 Topics: Acute Disease; Algorithms; Anticonvulsants; Antidepressive Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Clozapine; Dibenzothiazepines; Drug Therapy, Combination; Humans; Lithium; Olanzapine; Pirenzepine; Psychotic Disorders; Quetiapine Fumarate; Risperidone; Treatment Outcome; Valproic Acid	2000
Alternatives to lithium and divalproex in the maintenance treatment of bipolar disorder. Bipolar disorders, 2003, Volume: 5, Issue:3 Topics: Acetates; Amines; Anticonvulsants; Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Calcium Channel Blockers; Carbamazepine; Clozapine; Cyclohexanecarboxylic Acids; Dibenzothiazepines; Donepezil; Fatty Acids, Omega-3; Fructose; Gabapentin; gamma-Aminobutyric Acid; Humans; Indans; Lamotrigine; Lithium Carbonate; Olanzapine; Piperazines; Piperidines; Pirenzepine; Quetiapine Fumarate; Risperidone; Thiazoles; Topiramate; Treatment Outcome; Triazines; Valproic Acid	2003
A critical review of atypical antipsychotic utilization: comparing monotherapy with polypharmacy and augmentation. Current medicinal chemistry, 2004, Volume: 11, Issue:3 Topics: Acetates; Amines; Anticonvulsants; Antipsychotic Agents; Clinical Trials as Topic; Clozapine; Cyclohexanecarboxylic Acids; Drug Utilization; Gabapentin; gamma-Aminobutyric Acid; Humans; Polypharmacy; Risperidone; Schizophrenia; Valproic Acid	2004
[Psychotropics and weight gain]. Praxis, 2004, Aug-25, Volume: 93, Issue:35 Topics: Adolescent; Adult; Amisulpride; Antidepressive Agents; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Body Mass Index; Child; Clozapine; Dibenzothiazepines; Double-Blind Method; Female; Fructose; Haloperidol; Humans; Imidazoles; Indoles; Male; Obesity; Olanzapine; Piperazines; Placebos; Psychotropic Drugs; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Risperidone; Socioeconomic Factors; Sulpiride; Thiazoles; Time Factors; Topiramate; Valproic Acid; Weight Gain	2004
Management options for bipolar disorder in children and adolescents. Paediatric drugs, 2005, Volume: 7, Issue:5 Topics: Adolescent; Benzodiazepines; Bipolar Disorder; Carbamazepine; Child; Clozapine; Dibenzothiazepines; Humans; Lithium; Olanzapine; Quetiapine Fumarate; Risperidone; Valproic Acid	2005
Epigenetic dysregulation in schizophrenia: molecular and clinical aspects of histone deacetylase inhibitors. European archives of psychiatry and clinical neuroscience, 2013, Volume: 263, Issue:4 Topics: Antipsychotic Agents; Clozapine; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Epigenesis, Genetic; gamma-Aminobutyric Acid; Histone Deacetylase Inhibitors; Histones; Humans; Protein Processing, Post-Translational; Schizophrenia; Valproic Acid	2013
Hand therapy, 2016, Volume: 21, Issue:1 Topics: AC133 Antigen; Acenaphthenes; Acer; Acrosome Reaction; Adult; Agaricales; Aged; Aged, 80 and over; Animals; Animals, Zoo; Anti-Bacterial Agents; Anticoagulants; Antifungal Agents; Antimanic Agents; Antioxidants; Aortic Valve; Area Under Curve; ATP Binding Cassette Transporter, Subfamily G, Member 2; Bacillus; Bacterial Toxins; Bacterial Typing Techniques; Base Composition; Beauveria; Binge Drinking; Biomarkers; Bipolar Disorder; Blood Coagulation; Blotting, Western; Brachytherapy; Calcium Channels, L-Type; Carcinoma, Non-Small-Cell Lung; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cell Transformation, Neoplastic; Cell Wall; Cells, Cultured; Ceramics; Chi-Square Distribution; China; Chlorophyll; Chlorophyta; Chloroplasts; Cholesterol, HDL; Chromatography, High Pressure Liquid; Chromobacterium; Clostridium perfringens; Clozapine; Constriction, Pathologic; Coronary Artery Bypass; Corticotropin-Releasing Hormone; Cross-Sectional Studies; Cytochrome P-450 CYP2C9; Dental Porcelain; Dental Restoration Failure; Dental Stress Analysis; Designer Drugs; Diaminopimelic Acid; DNA Fingerprinting; DNA, Bacterial; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Drug Dosage Calculations; Drug Evaluation, Preclinical; Drug Resistance, Bacterial; Elasticity Imaging Techniques; Epsilonproteobacteria; Equipment Design; Ericaceae; Excitatory Amino Acid Antagonists; False Negative Reactions; Fatty Acids; Female; Food Analysis; Fresh Water; Gene Expression Regulation, Neoplastic; Glutathione; Graft Occlusion, Vascular; Heart Valve Prosthesis Implantation; Heart Ventricles; HEK293 Cells; Hemolymph; Humans; Hyaluronan Receptors; Hydrogen Peroxide; Hydrothermal Vents; Indoles; Inflammation Mediators; Inhibitory Concentration 50; Insecta; International Normalized Ratio; Isotope Labeling; Itraconazole; Kidney; Kinetics; Kruppel-Like Factor 4; Kruppel-Like Transcription Factors; Lamotrigine; Lanthanoid Series Elements; Limit of Detection; Linear Models; Lipid Peroxidation; Liver; Liver Cirrhosis; Logistic Models; Lung Neoplasms; Lymph Node Excision; Lymphatic Metastasis; Male; Malondialdehyde; Mediastinum; Metronidazole; Mice; Mice, Nude; Mice, Transgenic; Microbial Sensitivity Tests; Microscopy, Fluorescence; Middle Aged; Monocytes; Monomeric GTP-Binding Proteins; Multivariate Analysis; Myocytes, Cardiac; Neoplasm Staging; Neoplastic Stem Cells; Neural Pathways; Nitrates; Nucleic Acid Hybridization; Octamer Transcription Factor-3; Odds Ratio; Oxidation-Reduction; Oxidative Stress; Peptidoglycan; Phantoms, Imaging; Pharmacogenetics; Pharmacogenomic Variants; Phenotype; Phospholipids; Photolysis; Photosynthesis; Phylogeny; Plant Extracts; Polychaeta; Polymerase Chain Reaction; Polymorphism, Single Nucleotide; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Preoperative Care; Prostatic Neoplasms; Pseudomonas aeruginosa; Pyrimidines; Pyrroles; Quorum Sensing; Radiology, Interventional; Radiopharmaceuticals; Radiotherapy Dosage; Rats; Rats, Sprague-Dawley; Receptors, Corticotropin-Releasing Hormone; Reference Values; Regression Analysis; Retrospective Studies; Reverse Transcriptase Polymerase Chain Reaction; Rhizosphere; Risk Factors; RNA, Ribosomal, 16S; ROC Curve; Rutin; Saphenous Vein; Seawater; Selenium; Semen Preservation; Sensitivity and Specificity; Septal Nuclei; Sequence Analysis, DNA; Serum Albumin; Serum Albumin, Human; Shear Strength; Sodium Pertechnetate Tc 99m; Sodium-Hydrogen Exchangers; Soil Microbiology; SOXB1 Transcription Factors; Spain; Species Specificity; Sperm Motility; Spermatozoa; Spheroids, Cellular; Spores, Fungal; Stroke; Superoxide Dismutase; Swine; Tandem Mass Spectrometry; Technetium Compounds; Technetium Tc 99m Exametazime; Technetium Tc 99m Sestamibi; Temperature; Thiosulfates; Thrombosis; Thyroid Neoplasms; Transducers; Transfection; Transplantation, Heterologous; Treatment Outcome; Triazines; Tumor Burden; Urocortins; Uterine Cervical Neoplasms; Vacuoles; Valproic Acid; Ventral Tegmental Area; Vitamin K 2; Vitamin K Epoxide Reductases; Warfarin; Water Microbiology; Young Adult	2016
[Recommendations about the Use of Psychotropic Medications during the COVID-19 Pandemic]. Acta medica portuguesa, 2020, Oct-01, Volume: 33, Issue:10 Topics: Antiviral Agents; Benzodiazepines; Betacoronavirus; Bipolar Disorder; Body Temperature Regulation; Buprenorphine; Clozapine; Coronavirus Infections; COVID-19; Delayed-Action Preparations; Drug Interactions; Hospitalization; Humans; Lithium Compounds; Mental Disorders; Methadone; Narcotic Antagonists; Pandemics; Pneumonia, Viral; Psychotropic Drugs; SARS-CoV-2; Schizophrenia; Smoking Cessation Agents; Valproic Acid	2020
Risk factors for clozapine-induced myocarditis and cardiomyopathy: A systematic review and meta-analysis. Acta psychiatrica Scandinavica, 2022, Volume: 145, Issue:5 Topics: Antipsychotic Agents; Cardiomyopathies; Clozapine; Humans; Myocarditis; Risk Factors; Valproic Acid	2022

Trials

6 trial(s) available for valproic acid and clozapine

Article	Year
Serum concentrations of clozapine and its major metabolites: effects of cotreatment with fluoxetine or valproate. The American journal of psychiatry, 1994, Volume: 151, Issue:1 Topics: Adult; Clozapine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Fluoxetine; Humans; Male; Psychotic Disorders; Schizophrenia; Stimulation, Chemical; Valproic Acid	1994
Small effects of valproic acid on the plasma concentrations of clozapine and its major metabolites in patients with schizophrenic or affective disorders. Therapeutic drug monitoring, 1999, Volume: 21, Issue:3 Topics: Adult; Anticonvulsants; Antipsychotic Agents; Clozapine; Drug Interactions; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Mood Disorders; Schizophrenia; Valproic Acid	1999
Clozapine, diabetes mellitus, weight gain, and lipid abnormalities: A five-year naturalistic study. The American journal of psychiatry, 2000, Volume: 157, Issue:6 Topics: Adult; Age Factors; Antipsychotic Agents; Body Mass Index; Body Weight; Cholesterol; Clozapine; Diabetes Mellitus; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Family; Female; Genetic Predisposition to Disease; Humans; Hypercholesterolemia; Hypertriglyceridemia; Incidence; Male; Obesity; Psychotic Disorders; Risk Factors; Schizophrenia; Triglycerides; Valproic Acid	2000
A naturalistic comparison of clozapine, risperidone, and olanzapine in the treatment of bipolar disorder. The Journal of clinical psychiatry, 2000, Volume: 61, Issue:9 Topics: Adult; Antipsychotic Agents; Basal Ganglia Diseases; Benzodiazepines; Bipolar Disorder; Body Weight; Clozapine; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Lithium; Male; Olanzapine; Pirenzepine; Psychiatric Status Rating Scales; Retrospective Studies; Risperidone; Treatment Outcome; Valproic Acid	2000
Motor cortex excitability after vagus nerve stimulation in major depression. Journal of clinical psychopharmacology, 2007, Volume: 27, Issue:2 Topics: Adult; Benzodiazepines; Citalopram; Clomipramine; Clozapine; Depressive Disorder; Doxepin; Drug Therapy, Combination; Electric Stimulation; Female; Humans; Lamotrigine; Lithium Carbonate; Male; Mianserin; Middle Aged; Mirtazapine; Morpholines; Motor Cortex; Neural Conduction; Neural Inhibition; Olanzapine; Paroxetine; Psychiatric Status Rating Scales; Reboxetine; Tranylcypromine; Triazines; Vagus Nerve; Valproic Acid	2007
Assessment of the efficacy of omega-3 fatty acids on metabolic and inflammatory parameters in patients with schizophrenia taking clozapine and sodium valproate. Psychiatry research, 2018, Volume: 261 Topics: Adult; Anthropometry; Antipsychotic Agents; Body Mass Index; Body Weight; C-Reactive Protein; Clozapine; Dietary Supplements; Double-Blind Method; Fasting; Fatty Acids, Omega-3; Female; Humans; Male; Middle Aged; Schizophrenia; Treatment Outcome; Triglycerides; Valproic Acid; Waist Circumference	2018

Other Studies

98 other study(ies) available for valproic acid and clozapine

Article	Year
Functional group contributions to drug-receptor interactions. Journal of medicinal chemistry, 1984, Volume: 27, Issue:12 Topics: Animals; Calorimetry; Kinetics; Models, Biological; Protein Binding; Receptors, Cell Surface; Receptors, Drug; Structure-Activity Relationship	1984
QSAR model for drug human oral bioavailability. Journal of medicinal chemistry, 2000, Jun-29, Volume: 43, Issue:13 Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship	2000
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling. Current drug discovery technologies, 2004, Volume: 1, Issue:4 Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration	2004
Hologram QSAR model for the prediction of human oral bioavailability. Bioorganic & medicinal chemistry, 2007, Dec-15, Volume: 15, Issue:24 Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship	2007
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1. Journal of medicinal chemistry, 2008, Oct-09, Volume: 51, Issue:19 Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship	2008
Physicochemical determinants of human renal clearance. Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15 Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight	2009
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chemical research in toxicology, 2010, Volume: 23, Issue:1 Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship	2010
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models. Toxicology mechanisms and methods, 2008, Volume: 18, Issue:2-3 Topics:	2008
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination. Journal of medicinal chemistry, 2010, Feb-11, Volume: 53, Issue:3 Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations	2010
Developing structure-activity relationships for the prediction of hepatotoxicity. Chemical research in toxicology, 2010, Jul-19, Volume: 23, Issue:7 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes	2010
Predicting phospholipidosis using machine learning. Molecular pharmaceutics, 2010, Oct-04, Volume: 7, Issue:5 Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine	2010
A predictive ligand-based Bayesian model for human drug-induced liver injury. Drug metabolism and disposition: the biological fate of chemicals, 2010, Volume: 38, Issue:12 Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands	2010
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate. Bioorganic & medicinal chemistry letters, 2010, Dec-15, Volume: 20, Issue:24 Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility	2010
Combination of GSH trapping and time-dependent inhibition assays as a predictive method of drugs generating highly reactive metabolites. Drug metabolism and disposition: the biological fate of chemicals, 2011, Volume: 39, Issue:7 Topics: Glutathione; Pharmacology; Sulfur Radioisotopes	2011
FDA-approved drug labeling for the study of drug-induced liver injury. Drug discovery today, 2011, Volume: 16, Issue:15-16 Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration	2011
In vitro inhibition of the bile salt export pump correlates with risk of cholestatic drug-induced liver injury in humans. Drug metabolism and disposition: the biological fate of chemicals, 2012, Volume: 40, Issue:1 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Cholestasis; Drug-Related Side Effects and Adverse Reactions; Humans; Insecta; Rats; Risk Factors	2012
In silico assay for assessing phospholipidosis potential of small druglike molecules: training, validation, and refinement using several data sets. Journal of medicinal chemistry, 2012, Jan-12, Volume: 55, Issue:1 Topics: Animals; Cattle; Cells, Cultured; Computer Simulation; Cornea; Drug-Related Side Effects and Adverse Reactions; Fibroblasts; Lipidoses; Lysosomal Storage Diseases; Models, Molecular; Pharmaceutical Preparations; Phospholipids; Structure-Activity Relationship; Thermodynamics	2012
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds. Chemical research in toxicology, 2012, Oct-15, Volume: 25, Issue:10 Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding	2012
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification. Drug metabolism and disposition: the biological fate of chemicals, 2012, Volume: 40, Issue:12 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship	2012
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships. Bioorganic & medicinal chemistry letters, 2016, 08-15, Volume: 26, Issue:16 Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone	2016
Structure-anticonvulsant activity studies in the group of (E)-N-cinnamoyl aminoalkanols derivatives monosubstituted in phenyl ring with 4-Cl, 4-CH Bioorganic & medicinal chemistry, 2017, 01-15, Volume: 25, Issue:2 Topics: Amino Alcohols; Animals; Anticonvulsants; Crystallography, X-Ray; Disease Models, Animal; Dose-Response Relationship, Drug; Electroshock; Mice; Models, Molecular; Molecular Structure; Rats; Seizures; Structure-Activity Relationship	2017
Effects of a GABA-mimetic drug (sodium valproate) on visually evoked potentials in chronic schizophrenics. Neuropsychobiology, 1984, Volume: 11, Issue:1 Topics: Adult; Brain; Brief Psychiatric Rating Scale; Chronic Disease; Clozapine; Dibenzazepines; Drug Therapy, Combination; Evoked Potentials, Visual; Female; gamma-Aminobutyric Acid; Humans; Middle Aged; Schizophrenia; Valproic Acid	1984
Valproic acid effects on serum concentrations of clozapine and norclozapine. The American journal of psychiatry, 1995, Volume: 152, Issue:4 Topics: Clozapine; Depression, Chemical; Drug Therapy, Combination; Humans; Schizophrenia; Seizures; Valproic Acid	1995
A clinically significant interaction between clozapine and valproate. Journal of clinical psychopharmacology, 1995, Volume: 15, Issue:2 Topics: Adult; Arousal; Bipolar Disorder; Clozapine; Confusion; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Humans; Lithium; Male; Orientation; Psychotic Disorders; Speech Disorders; Valproic Acid	1995
Potential impact of valproic acid therapy on clozapine disposition. Biological psychiatry, 1994, Oct-01, Volume: 36, Issue:7 Topics: Adult; Clozapine; Drug Interactions; Humans; Male; Middle Aged; Pilot Projects; Schizophrenia; Valproic Acid	1994
Concurrent use of clozapine and valproate in affective and psychotic disorders. The Journal of clinical psychiatry, 1994, Volume: 55, Issue:6 Topics: Adult; Clozapine; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Incidence; Leukopenia; Liver; Liver Function Tests; Male; Middle Aged; Psychotic Disorders; Seizures; Sleep; Treatment Outcome; Valproic Acid	1994
Valproic acid treatment of clozapine-induced myoclonus. The American journal of psychiatry, 1994, Volume: 151, Issue:8 Topics: Adult; Clozapine; Drug Administration Schedule; Female; Humans; Myoclonus; Receptors, Serotonin; Schizophrenia; Seizures; Valproic Acid	1994
Tissue concentrations of clozapine and its metabolites in the rat. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 1993, Volume: 9, Issue:2 Topics: Animals; Brain; Clozapine; Fluoxetine; Half-Life; Male; Mass Spectrometry; Rats; Rats, Sprague-Dawley; Valproic Acid	1993
Monozygotic twins concordant for response to clozapine. Lancet (London, England), 1996, Jan-06, Volume: 347, Issue:8993 Topics: Adult; Antipsychotic Agents; Clozapine; Diseases in Twins; Drug Therapy, Combination; Humans; Male; Schizophrenia; Twins, Monozygotic; Valproic Acid	1996
Medication optimization during clozapine treatment. The Journal of clinical psychiatry, 1996, Volume: 57, Issue:7 Topics: 1-Naphthylamine; Adult; Clozapine; Drug Therapy, Combination; Humans; Lithium; Male; Obsessive-Compulsive Disorder; Psychotic Disorders; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome; Valproic Acid	1996
Clozapine-induced stuttering: epileptic brain activity? The American journal of psychiatry, 1999, Volume: 156, Issue:10 Topics: Anticonvulsants; Antipsychotic Agents; Brain; Clozapine; Dose-Response Relationship, Drug; Electroencephalography; Epilepsy, Generalized; Female; Humans; Middle Aged; Phenytoin; Schizophrenia, Paranoid; Stuttering; Valproic Acid	1999
Diabetic ketoacidosis with clozapine treatment. Diabetes, nutrition & metabolism, 1999, Volume: 12, Issue:2 Topics: Antimanic Agents; Antipsychotic Agents; Bipolar Disorder; Clozapine; Diabetic Ketoacidosis; Drug Therapy, Combination; Female; Humans; Middle Aged; Valproic Acid	1999
Hepatic encephalopathy associated with combined clozapine and divalproex sodium treatment. Journal of clinical psychopharmacology, 1997, Volume: 17, Issue:2 Topics: Adult; Clozapine; Drug Interactions; Enzyme Inhibitors; Female; Hepatic Encephalopathy; Humans; Serotonin Antagonists; Valproic Acid	1997
Lamotrigine and clozapine for bipolar disorder. The American journal of psychiatry, 2000, Volume: 157, Issue:9 Topics: Antidepressive Agents; Antipsychotic Agents; Bipolar Disorder; Clozapine; Drug Therapy, Combination; Humans; Lamotrigine; Male; Middle Aged; Treatment Outcome; Triazines; Valproic Acid	2000
Clozapine therapy for a patient with a history of Hodgkin's disease. Psychiatric services (Washington, D.C.), 2001, Volume: 52, Issue:1 Topics: Adult; Antipsychotic Agents; Bipolar Disorder; Clozapine; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Leukopenia; Remission Induction; Risperidone; Treatment Outcome; Valproic Acid	2001
A case of pharmacokinetic interference in comedication of clozapine and valproic acid. Pharmacopsychiatry, 2000, Volume: 33, Issue:6 Topics: Adult; Anticonvulsants; Clozapine; Drug Interactions; Drug Therapy, Combination; Epilepsy, Generalized; Female; GABA Antagonists; Humans; Valproic Acid	2000
Simultaneous side effects of both clozapine and valproate. Intensive care medicine, 2001, Volume: 27, Issue:5 Topics: Adult; Anticonvulsants; Antipsychotic Agents; Carnitine; Clozapine; Coma; Diabetic Ketoacidosis; Drug Interactions; Humans; Hyperammonemia; Male; Valproic Acid	2001
Increased risk of neutropaenia and agranulocytosis with sodium valproate used adjunctively with clozapine. The Australian and New Zealand journal of psychiatry, 2001, Volume: 35, Issue:4 Topics: Adult; Agranulocytosis; Anticonvulsants; Antipsychotic Agents; Clozapine; Drug Therapy, Combination; Female; Humans; Neutropenia; Risk Factors; Schizophrenia; Valproic Acid	2001
Combined clozapine and valproic acid treatment-induced agranulocytosis. European psychiatry : the journal of the Association of European Psychiatrists, 2002, Volume: 17, Issue:4 Topics: Agranulocytosis; Anticonvulsants; Chronic Disease; Clozapine; Drug Therapy, Combination; Humans; Male; Middle Aged; Schizophrenia, Paranoid; Serotonin Antagonists; Valproic Acid	2002
Lack of effect of mood stabilizers or neuroleptics on GSK-3 protein levels and GSK-3 activity. The international journal of neuropsychopharmacology, 2003, Volume: 6, Issue:2 Topics: Affect; Animals; Antimanic Agents; Antipsychotic Agents; Blotting, Western; Chlorpromazine; Clozapine; Frontal Lobe; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Haloperidol; Lithium; Rats; Rats, Sprague-Dawley; Valproic Acid	2003
Worsening of psychosis after replacement of adjunctive valproate with topiramate in a schizophrenia patient. The Journal of clinical psychiatry, 2003, Volume: 64, Issue:10 Topics: Adult; Anticonvulsants; Clozapine; Disease Progression; Dose-Response Relationship, Drug; Drug Therapy, Combination; Fructose; Humans; Male; Psychiatric Status Rating Scales; Schizophrenia, Paranoid; Sertraline; Topiramate; Valproic Acid	2003
Dosing differences between valproic acid concentrate and divalproex sodium: a case report. The Journal of clinical psychiatry, 2004, Volume: 65, Issue:5 Topics: Administration, Oral; Adult; Antipsychotic Agents; Biological Availability; Clozapine; Delayed-Action Preparations; Dose-Response Relationship, Drug; Humans; Intestinal Absorption; Male; Schizophrenia; Seizures; Valproic Acid	2004
Leukopenia in clozapine treated patients may be induced by other drugs: a case series. European psychiatry : the journal of the Association of European Psychiatrists, 2004, Volume: 19, Issue:8 Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Clozapine; Drug Resistance; Female; Humans; Leukocyte Count; Leukopenia; Lithium Carbonate; Male; Middle Aged; Valproic Acid	2004
A case of clozapine-induced tonic-clonic seizures managed with valproate: implications for clinical care. Journal of psychopharmacology (Oxford, England), 2005, Volume: 19, Issue:1 Topics: Adult; Anticonvulsants; Antipsychotic Agents; Clozapine; Epilepsy, Tonic-Clonic; Female; Humans; Schizophrenia, Paranoid; Valproic Acid	2005
Clozapine-induced stuttering, facial tics and myoclonic seizures: a case report. The Australian and New Zealand journal of psychiatry, 2005, Volume: 39, Issue:3 Topics: Antipsychotic Agents; Clozapine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Epilepsies, Myoclonic; Humans; Male; Schizophrenia; Stuttering; Tics; Valproic Acid	2005
Worsening of psychotic symptoms in schizophrenia with addition of lamotrigine: a case report. Schizophrenia research, 2005, Oct-15, Volume: 78, Issue:2-3 Topics: Adult; Antipsychotic Agents; Brain; Clozapine; Drug Therapy, Combination; Female; Humans; Lamotrigine; Lithium Carbonate; Magnetic Resonance Imaging; Psychotic Disorders; Schizophrenia; Severity of Illness Index; Triazines; Valproic Acid	2005
Plasma clozapine levels and clinical response in treatment-refractory Chinese schizophrenic patients. Progress in neuro-psychopharmacology & biological psychiatry, 2006, Volume: 30, Issue:2 Topics: Adolescent; Adult; Aged; Anticonvulsants; Antipsychotic Agents; China; Chromatography, High Pressure Liquid; Clozapine; Drug Interactions; Electrochemistry; Female; Humans; Male; Middle Aged; ROC Curve; Schizophrenia; Sensitivity and Specificity; Statistics, Nonparametric; Time Factors; Valproic Acid	2006
Adjunct divalproex or lithium to clozapine in treatment-resistant schizophrenia. The Psychiatric quarterly, 2006,Spring, Volume: 77, Issue:1 Topics: Adult; Anticonvulsants; Antimanic Agents; Antipsychotic Agents; Anxiety; Blood Glucose; Brief Psychiatric Rating Scale; Clozapine; Drug Resistance; Drug Therapy, Combination; Female; Hostility; Humans; Lithium Carbonate; Male; Middle Aged; Prospective Studies; Retrospective Studies; Schizophrenia; Schizophrenic Psychology; Valproic Acid; Weight Gain	2006
Severe impulsiveness as the primary manifestation of multiple sclerosis in a young female. Psychiatry and clinical neurosciences, 2005, Volume: 59, Issue:6 Topics: Adolescent; Adult; Antimanic Agents; Antipsychotic Agents; Child; Clozapine; Female; Homicide; Humans; Impulsive Behavior; Magnetic Resonance Imaging; Masturbation; Multiple Sclerosis; Personality; Psychotropic Drugs; Sex Work; Sexual Behavior; Substance-Related Disorders; Suicide; Valproic Acid	2005
Clozapine-induced pericarditis, pericardial tamponade, polyserositis, and rash. The Journal of clinical psychiatry, 2005, Volume: 66, Issue:11 Topics: Adult; Anticonvulsants; Antipsychotic Agents; Cardiac Tamponade; Clozapine; Drug Eruptions; Drug Therapy, Combination; Female; Humans; Pericardial Effusion; Pericarditis; Pleural Effusion; Schizophrenia; Serositis; Valproic Acid	2005
Glycopyrrolate for clozapine-induced sialorrhea. Progress in neuro-psychopharmacology & biological psychiatry, 2007, Oct-01, Volume: 31, Issue:7 Topics: Adult; Antimanic Agents; Antipsychotic Agents; Clozapine; Fluphenazine; Glycopyrrolate; Humans; Male; Muscarinic Antagonists; Psychotic Disorders; Sialorrhea; Valproic Acid	2007
Augmentation of clozapine with valproic Acid for clozapine-induced obsessive-compulsive symptoms. Pharmacopsychiatry, 2007, Volume: 40, Issue:5 Topics: Adult; Antimanic Agents; Antipsychotic Agents; Clozapine; Drug Therapy, Combination; Humans; Male; Obsessive-Compulsive Disorder; Psychiatric Status Rating Scales; Schizophrenia; Valproic Acid	2007
Increased left prefrontal activation during staring/mutism episodes in a patient with resistant catatonic schizophrenia: a near infrared spectroscopy study. Cognitive and behavioral neurology : official journal of the Society for Behavioral and Cognitive Neurology, 2008, Volume: 21, Issue:1 Topics: Adult; Attention; Awareness; Catalepsy; Clozapine; Combined Modality Therapy; Dominance, Cerebral; Drug Resistance; Electroconvulsive Therapy; Fixation, Ocular; Humans; Image Processing, Computer-Assisted; Imaging, Three-Dimensional; Lorazepam; Male; Mutism; Oxyhemoglobins; Prefrontal Cortex; Regional Blood Flow; Schizophrenia, Catatonic; Spectroscopy, Near-Infrared; Valproic Acid	2008
Clozapine and sulpiride but not haloperidol or olanzapine activate brain DNA demethylation. Proceedings of the National Academy of Sciences of the United States of America, 2008, Sep-09, Volume: 105, Issue:36 Topics: Acetylation; Animals; Benzodiazepines; Brain; Cell Adhesion Molecules, Neuronal; Clozapine; DNA Methylation; Extracellular Matrix Proteins; Glutamate Decarboxylase; Haloperidol; Histones; Lysine; Male; Mice; Nerve Tissue Proteins; Olanzapine; Promoter Regions, Genetic; Reelin Protein; Serine Endopeptidases; Sulpiride; Valproic Acid	2008
Adjunctive medication effects may increase risk for neutropenia. The American journal of psychiatry, 2008, Volume: 165, Issue:12 Topics: Antipsychotic Agents; Chemotherapy, Adjuvant; Clozapine; Drug Administration Schedule; Humans; Neutropenia; Psychotic Disorders; Risk Factors; Valproic Acid	2008
The incidence and characteristics of clozapine- induced fever in a local psychiatric unit in Hong Kong. Canadian journal of psychiatry. Revue canadienne de psychiatrie, 2008, Volume: 53, Issue:12 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticonvulsants; Antipsychotic Agents; Bipolar Disorder; Clozapine; Cross-Sectional Studies; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Fever; Hong Kong; Humans; Incidence; Male; Middle Aged; Psychiatric Department, Hospital; Psychotic Disorders; Retrospective Studies; Risk Factors; Schizophrenia; Valproic Acid; Young Adult	2008
Extreme elevation of creatinine phosphokinase levels in neuroleptic malignant syndrome associated with atypical antipsychotics. The American journal of psychiatry, 2009, Volume: 166, Issue:1 Topics: Adult; Antipsychotic Agents; Aripiprazole; Clozapine; Creatine Kinase; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Humans; Male; Myocardial Infarction; Neuroleptic Malignant Syndrome; Piperazines; Quinolones; Risperidone; Schizophrenia; Valproic Acid	2009
Eosinophilic pleural effusion associated with the addition of sodium valproate. Journal of clinical psychopharmacology, 2009, Volume: 29, Issue:3 Topics: Antimanic Agents; Antipsychotic Agents; Clozapine; Drug Therapy, Combination; Eosinophilia; Female; Humans; Middle Aged; Pleural Effusion; Valproic Acid	2009
Infection or idiosyncratic reaction to antiepileptic drugs? Psychiatria Danubina, 2010, Volume: 22, Issue:1 Topics: Adult; Anticonvulsants; Antipsychotic Agents; Bipolar Disorder; Clozapine; Diagnosis, Differential; Drug Therapy, Combination; Humans; Lamotrigine; Male; Pericarditis; Respiratory Insufficiency; Systemic Inflammatory Response Syndrome; Triazines; Valproic Acid	2010
Folie à deux: double case-report of shared delusions with a fatal outcome. La Clinica terapeutica, 2011, Volume: 162, Issue:1 Topics: Adult; Anticonvulsants; Antipsychotic Agents; Benzodiazepines; Clozapine; Combined Modality Therapy; Epilepsy; Fatal Outcome; Female; Haloperidol; Humans; Nordazepam; Olanzapine; Patient Compliance; Psychotherapy; Psychotic Disorders; Schizophrenia, Paranoid; Shared Paranoid Disorder; Sibling Relations; Suicide; Valproic Acid	2011
Pharmacological treatment of deep brain stimulation-induced hypomania leads to clinical remission while preserving motor benefits. Neurocase, 2012, Volume: 18, Issue:2 Topics: Antimanic Agents; Bipolar Disorder; Clozapine; Deep Brain Stimulation; Humans; Male; Middle Aged; Parkinson Disease; Treatment Outcome; Valproic Acid	2012
The effects of neuropsychiatric drugs on glycogen synthase kinase-3 signaling. Neuroscience, 2011, Dec-29, Volume: 199 Topics: Animals; Antidepressive Agents; Antimanic Agents; Antipsychotic Agents; beta Catenin; Blotting, Western; Brain; Clozapine; Fluoxetine; Glycogen Synthase Kinase 3; Haloperidol; Imipramine; Immunoprecipitation; Lithium; Male; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Signal Transduction; Valproic Acid	2011
Persistent febrile illness with multisystem organ failure associated with clozapine. Internal medicine journal, 2012, Volume: 42, Issue:1 Topics: Abdominal Pain; Adult; Antipsychotic Agents; Clozapine; Combined Modality Therapy; Diagnostic Errors; Dibenzothiazepines; Drug Therapy, Combination; Female; Fever; Fluid Therapy; Headache; Hemodiafiltration; Humans; Lithium; Multiple Organ Failure; Norepinephrine; Quetiapine Fumarate; Schizophrenia; Systemic Inflammatory Response Syndrome; Urinary Tract Infections; Valproic Acid; Vasoconstrictor Agents	2012
Valproic acid augmentation in clozapine-associated hand-washing compulsion. Psychiatry and clinical neurosciences, 2012, Volume: 66, Issue:5 Topics: Anticonvulsants; Antipsychotic Agents; Clozapine; Compulsive Behavior; Hand Disinfection; Humans; Male; Middle Aged; Schizophrenia; Valproic Acid	2012
Rapid clozapine dose titration and concomitant sodium valproate increase the risk of myocarditis with clozapine: a case-control study. Schizophrenia research, 2012, Volume: 141, Issue:2-3 Topics: Adolescent; Adult; Age Factors; Aged; Anticonvulsants; Antipsychotic Agents; Area Under Curve; Body Mass Index; Case-Control Studies; Clozapine; Dose-Response Relationship, Drug; Drug Synergism; Female; Humans; Male; Middle Aged; Myocarditis; Retrospective Studies; Schizophrenia; Time Factors; Valproic Acid; Young Adult	2012
Clinical predictors of serum clozapine levels in patients with treatment-resistant schizophrenia. International clinical psychopharmacology, 2013, Volume: 28, Issue:1 Topics: Administration, Oral; Adult; Anticonvulsants; Antipsychotic Agents; Caffeine; Case-Control Studies; Central Nervous System Stimulants; Chi-Square Distribution; Chromatography, High Pressure Liquid; Clozapine; Cross-Sectional Studies; Drug Interactions; Drug Monitoring; Drug Resistance; Female; Food-Drug Interactions; Humans; Least-Squares Analysis; Logistic Models; Male; Middle Aged; Multivariate Analysis; Odds Ratio; Psychiatric Status Rating Scales; Risk Factors; Schizophrenia; Schizophrenic Psychology; Spectrophotometry, Ultraviolet; Treatment Failure; Valproic Acid	2013
Antipsychotic drugs, mood stabilizers, and risk of pneumonia in bipolar disorder: a nationwide case-control study. The Journal of clinical psychiatry, 2013, Volume: 74, Issue:1 Topics: Adolescent; Adult; Anticonvulsants; Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Carbamazepine; Case-Control Studies; Clozapine; Cohort Studies; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Evidence-Based Medicine; Female; Hospitalization; Humans; Lithium Carbonate; Male; Middle Aged; Multivariate Analysis; Olanzapine; Pneumonia; Propensity Score; Risk Factors; Taiwan; Valproic Acid; Young Adult	2013
A case report that suggested that aspirin's effects on valproic acid metabolism may contribute to valproic acid's inducer effects on clozapine metabolism. Journal of clinical psychopharmacology, 2013, Volume: 33, Issue:6 Topics: Adult; Antimanic Agents; Antipsychotic Agents; Aspirin; Bipolar Disorder; Clozapine; Dose-Response Relationship, Drug; Drug Interactions; Humans; Male; Valproic Acid	2013
Precursor manic behavior in the assessment and treatment of episodic problem behavior for a woman with a dual diagnosis. Journal of applied behavior analysis, 2013,Fall, Volume: 46, Issue:3 Topics: Antimanic Agents; Antipsychotic Agents; Attention Deficit Disorder with Hyperactivity; Behavioral Symptoms; Clozapine; Diagnosis, Dual (Psychiatry); Female; Humans; Mental Disorders; Middle Aged; Psychiatric Status Rating Scales; Valproic Acid	2013
Successful treatment of catatonia in a young man with schizophrenia and progressive diffuse cerebral atrophy. The Journal of neuropsychiatry and clinical neurosciences, 2014,Winter, Volume: 26, Issue:1 Topics: Adolescent; Amantadine; Anticonvulsants; Antiparkinson Agents; Antipsychotic Agents; Atrophy; Catatonia; Cerebral Cortex; Clozapine; Drug Therapy, Combination; Humans; Magnetic Resonance Imaging; Male; Memantine; Schizophrenia; Valproic Acid	2014
Valproate reverts zinc and potassium imbalance in schizophrenia-derived reprogrammed cells. Schizophrenia research, 2014, Volume: 154, Issue:1-3 Topics: Antipsychotic Agents; Cell Line; Clozapine; Drug Resistance; Embryonic Stem Cells; Humans; Induced Pluripotent Stem Cells; Neural Stem Cells; Potassium; Schizophrenia; Valproic Acid; Zinc	2014
Can valproic acid be an inducer of clozapine metabolism? Pharmacopsychiatry, 2014, Volume: 47, Issue:3 Topics: Antimanic Agents; Chromatography, High Pressure Liquid; Clozapine; Drug Monitoring; Female; Humans; Linear Models; Male; Mental Disorders; Sex Factors; Smoking; Valproic Acid	2014
Clozapine-related pericarditis during titration phase in a patient with resistant schizophrenia and concomitant valproate treatment: a case report. Journal of clinical psychopharmacology, 2014, Volume: 34, Issue:5 Topics: Adult; Antipsychotic Agents; Clozapine; Drug Resistance; Drug Therapy, Combination; Humans; Indomethacin; Male; Pericarditis; Schizophrenia; Valproic Acid	2014
Skating on thin ice: pragmatic prescribing for medication refractory schizophrenia. BMC psychiatry, 2015, Jul-25, Volume: 15 Topics: Adult; Amisulpride; Antipsychotic Agents; Benzodiazepines; Clozapine; Drug Prescriptions; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Olanzapine; Quetiapine Fumarate; Schizophrenia; Schizophrenic Psychology; Sulpiride; Valproic Acid	2015
Optimizing outcomes in clozapine rechallenge following neutropenia: a cohort analysis. The Journal of clinical psychiatry, 2015, Volume: 76, Issue:11 Topics: Adult; Antimanic Agents; Antipsychotic Agents; Clozapine; Cohort Studies; Drug Therapy, Combination; Female; Granulocyte Colony-Stimulating Factor; Humans; Leukocyte Count; Lithium Compounds; Male; Middle Aged; Neutropenia; Neutrophils; Outcome Assessment, Health Care; Schizophrenia; Valproic Acid; Young Adult	2015
Ibuprofen May Increase Pharmacological Action of Valproate by Displacing It From Plasma Proteins: A Case Report. The American journal of psychiatry, 2016, 09-01, Volume: 173, Issue:9 Topics: Antipsychotic Agents; Blood Proteins; Clozapine; Drug Synergism; Drug Therapy, Combination; Humans; Ibuprofen; Male; Schizophrenia; Valproic Acid; Young Adult	2016
Clozapine-Valproate Adverse Drug Reactions and the Need for a Clozapine Rechallenge Case File. The primary care companion for CNS disorders, 2017, Jan-05, Volume: 19, Issue:1 Topics: Acute Kidney Injury; Antimanic Agents; Antipsychotic Agents; Clozapine; Drug Therapy, Combination; Humans; Male; Middle Aged; Pancreatitis; Psychotic Disorders; Valproic Acid	2017
Sodium valproate and clozapine induced neutropenia: A case control study using register data. Schizophrenia research, 2018, Volume: 195 Topics: Adolescent; Adult; Aged; Antimanic Agents; Antipsychotic Agents; Case-Control Studies; Clozapine; Female; Humans; Male; Middle Aged; Neutropenia; Registries; Valproic Acid; Young Adult	2018
Effect of Valproate and Antidepressant Drugs on Clozapine Metabolism in Patients With Psychotic Mood Disorders. Therapeutic drug monitoring, 2018, Volume: 40, Issue:4 Topics: Adolescent; Adult; Antidepressive Agents; Antimanic Agents; Antipsychotic Agents; Bipolar Disorder; Clozapine; Drug Interactions; Female; Humans; Male; Middle Aged; Retrospective Studies; Sex Factors; Valproic Acid; Young Adult	2018
Comedication of Valproic Acid Is Associated With Increased Metabolism of Clozapine. Journal of clinical psychopharmacology, 2018, Volume: 38, Issue:3 Topics: Adult; Antimanic Agents; Antipsychotic Agents; Clozapine; Drug Interactions; Drug Monitoring; Female; Humans; Male; Middle Aged; Psychotic Disorders; Retrospective Studies; Valproic Acid	2018
Clozapine toxicity in a CYP2D6 poor metaboliser: Additive effects of haloperidol and valproate on clozapine metabolism. Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists, 2018, Volume: 26, Issue:6 Topics: Adult; Antipsychotic Agents; Clozapine; Cytochrome P-450 CYP2D6; Drug Synergism; Haloperidol; Humans; Male; Schizophrenia; Valproic Acid; Young Adult	2018
Association between electroencephalogram changes and plasma clozapine levels in clozapine-treated patients. International clinical psychopharmacology, 2019, Volume: 34, Issue:3 Topics: Adult; Antipsychotic Agents; Bipolar Disorder; Clozapine; Drug Monitoring; Electroencephalography; Female; Humans; Male; Middle Aged; Retrospective Studies; Schizophrenia; Treatment Outcome; Valproic Acid	2019
Failure of rechallenge clozapine after agranulocytosis: A case report. L'Encephale, 2019, Volume: 45, Issue:5 Topics: Adult; Agranulocytosis; Antipsychotic Agents; Clopenthixol; Clozapine; Drug Resistance; Drug Substitution; Drug Synergism; Drug Therapy, Combination; Humans; Male; Olanzapine; Schizophrenia, Paranoid; Valproic Acid	2019
Reduction in N-Desmethylclozapine Level Is Determined by Daily Dose But Not Serum Concentration of Valproic Acid-Indications of a Presystemic Interaction Mechanism. Therapeutic drug monitoring, 2019, Volume: 41, Issue:4 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticonvulsants; Clozapine; Drug Interactions; Drug Monitoring; Female; Humans; Male; Middle Aged; Retrospective Studies; Valproic Acid; Young Adult	2019
A comparative study of detection of myocarditis induced by clozapine: With and without cardiac monitoring. Psychiatry research, 2019, Volume: 279 Topics: Adult; Antipsychotic Agents; Clozapine; Drug Therapy, Combination; Female; Humans; Incidence; Inpatients; Lithium; Male; Middle Aged; Monitoring, Physiologic; Myocarditis; Psychotic Disorders; Risk Factors; Valproic Acid; Young Adult	2019
Future Studies on the Interaction Between Clozapine and Valproic Acid Should Aspire to Include Longitudinal Designs and Free Valproate Concentrations, and Should Consider that Inducer and/or Inhibitory Effects May Vary With Time, the Individual, and the A Therapeutic drug monitoring, 2020, Volume: 42, Issue:1 Topics: Clozapine; Cytochrome P-450 Enzyme Inducers; Humans; Valproic Acid	2020
Clozapine-induced myocarditis during co-administration of valproate: A case report. Psychiatria polska, 2019, Oct-30, Volume: 53, Issue:5 Topics: Antipsychotic Agents; Clozapine; Drug Therapy, Combination; Humans; Male; Myocarditis; Schizophrenia; Valproic Acid; Young Adult	2019
Activation of Astroglial Connexin is Involved in Concentration-Dependent Double-Edged Sword Clinical Action of Clozapine. Cells, 2020, 02-11, Volume: 9, Issue:2 Topics: Antipsychotic Agents; Astrocytes; Cell Membrane; Clozapine; Connexin 43; Glutamic Acid; Humans; Myocarditis; Schizophrenia; Serine; Valproic Acid	2020
Effect of venlafaxine dosage, valproic acid concentration, sex, and age on steady state dose-corrected concentrations of venlafaxine and O-desmethylvenlafaxine: A retrospective analysis of therapeutic drug monitoring data in a Chinese population. Human psychopharmacology, 2020, Volume: 35, Issue:3 Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Asian People; Clozapine; Desvenlafaxine Succinate; Drug Interactions; Drug Monitoring; Female; Humans; Male; Middle Aged; Polypharmacy; Retrospective Studies; Sex Factors; Valproic Acid; Venlafaxine Hydrochloride; Young Adult	2020
[Thoughts on a favourable evolution of a COVID-19 in a patient with resistant schizophrenia and on a combination of clozapine and paliperidone palmitate]. L'Encephale, 2020, Volume: 46, Issue:3S Topics: Anticonvulsants; Antipsychotic Agents; Betacoronavirus; Clozapine; Coronavirus Infections; COVID-19; Delayed-Action Preparations; Drug Resistance; Drug Therapy, Combination; Humans; Immunologic Factors; Lithium Carbonate; Male; Middle Aged; Paliperidone Palmitate; Pandemics; Pneumonia, Viral; Psychotic Disorders; SARS-CoV-2; Sialorrhea; Treatment Outcome; Valproic Acid	2020
An International Adult Guideline for Making Clozapine Titration Safer by Using Six Ancestry-Based Personalized Dosing Titrations, CRP, and Clozapine Levels. Pharmacopsychiatry, 2022, Volume: 55, Issue:2 Topics: Adult; Antipsychotic Agents; Asian People; C-Reactive Protein; Clozapine; Female; Humans; Male; Valproic Acid	2022
Four cases of myocarditis in US hospitals possibly associated with clozapine poor metabolism and a comparison with prior published cases. Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet lapja = official journal of the Hungarian Association of Psychopharmacology, 2022, 03-01, Volume: 24, Issue:1 Topics: Antipsychotic Agents; Clozapine; Hospitals; Humans; Male; Myocarditis; Obesity; Schizophrenia; Valproic Acid	2022
Pharmacokinetic interactions between clozapine and valproic acid in patients with treatment-resistant schizophrenia: Does UGT polymorphism affect these drug interactions? Chemico-biological interactions, 2022, Sep-01, Volume: 364 Topics: Albumins; Antipsychotic Agents; Chromatography, Liquid; Clozapine; Cytochrome P-450 CYP2C19; Drug Interactions; Glucuronosyltransferase; Humans; Schizophrenia; Schizophrenia, Treatment-Resistant; Tandem Mass Spectrometry; Valproic Acid	2022
Confusion, Rigidity, and Elevated Creatine Phosphokinase: Atypical Neuroleptic Malignant Syndrome Possibly Associated With Clozapine and Sodium Valproate Use. The primary care companion for CNS disorders, 2022, 09-29, Volume: 24, Issue:5 Topics: Antipsychotic Agents; Clozapine; Creatine Kinase; Humans; Neuroleptic Malignant Syndrome; Valproic Acid	2022
Valproate-related neutropenia and lithium-related leukocytosis in patients treated with clozapine: a retrospective cohort study. BMC psychiatry, 2023, 03-15, Volume: 23, Issue:1 Topics: Antipsychotic Agents; Benzodiazepines; Clozapine; Humans; Leukocytosis; Lithium; Male; Neutropenia; Retrospective Studies; Valproic Acid	2023
Effect of smoking habits and concomitant valproic acid use on relapse in patients with treatment-resistant schizophrenia receiving clozapine: A 1-year retrospective cohort study. Acta psychiatrica Scandinavica, 2023, Volume: 148, Issue:5 Topics: Antipsychotic Agents; Clozapine; Habits; Humans; Retrospective Studies; Schizophrenia; Schizophrenia, Treatment-Resistant; Smoking; Valproic Acid	2023
Association of clozapine and norclozapine levels with patient and therapy characteristics-focus on interaction with valproic acid. European journal of clinical pharmacology, 2023, Volume: 79, Issue:11 Topics: Clozapine; Humans; Mental Disorders; Retrospective Studies; Valproic Acid	2023